Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Case Report on Problems with Generics Presented
December 18, 2006
- BUSINESS NEWS IN BRIEF
December 18, 2006
- Synix to Launch Improved Cancer Treatment Database
December 18, 2006
- PhRMA
December 11, 2006
- NEW PRODUCTS
December 11, 2006
- Survey Reveals Major Gap in New Drug Access in US/EU vs. Japan
December 11, 2006
- MEDICAL DEVICE NEWS IN BRIEF
December 11, 2006
- 4 New Drugs Recommended for Approval by 2nd Committee on Drugs
December 11, 2006
- NEW PRODUCTS
December 11, 2006
- 9 New Drugs Recommended for Approval by 1st Committee on Drugs
December 11, 2006
- SSP Plans to Develop OTC Drugs Using Western Herbs
December 11, 2006
- IHOKEN FORUM 2006
December 11, 2006
- SURVEY of Korosho
December 11, 2006
- REGULATORY NEWS IN BRIEF
December 11, 2006
- Addition of Guidant Enhances Abbott Vascular's Global Presence: Mr D. C. Bryant
December 11, 2006
- TOPIC an article
December 11, 2006
- Chugai Announces Strategic Goals for 2010
December 11, 2006
- Teijin to Promote "R&D Fully Integrated with Management": Mr Yamagishi
December 11, 2006
- Banyu Begins Detailing Preminent, a Combination Drug for Hypertension
December 11, 2006
- GSK to Discontinue Research in Japan
December 11, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…